CellaVision Annual Report 2006
2006 in Figures 
  • Net salses increased by 40% to SEK 54.8 million (39) 
  • Operating loss improved by SEK 7.9 million to -8.6 million (-16.5) and net loss amounted to -8.8 million (-16.7) 
  • Net loss per share amounted to SEK -0.37 million (-0.81) 
  • Liquid amounts were SEK 16.8 million (17.6) by the 31st December, 2006
Significant Events 2006 
  • The exclusive distribution agreements with Sysmex Europe and Sysmex America were extended by three years and several markets were added. 
  • Transfer of production of CellaVision(TM) DM96 to Kitron Flen AB was completed. 
  • ISO-certification was obtained (ISO-13485:2003). 
  • In the Nordic region several hospitals replaced their first CellaVision systems with the most recent generation of systems, CellaVision(TM) DM. 
  • Products were delivered to the first clients in Canada.

Annual Report 2006